Clinical Trial Update: A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis [Phase 3]

View source ↗

Summary

A Phase 3 double-blind, randomized, cross-over trial comparing Creon N to Creon in subjects aged 12 or older with pancreatic exocrine insufficiency due to cysti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pancreatic Exocrine Insufficiency

Drugs mentioned

• Creon (pancrelipase)
• Creon N (pancrelipase)

Snippet

Sponsor: Abbott | Conditions: Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2015-11-27